Constellation Pharmaceuticals, Inc.
CNST
CNST was delisted on the 14th of July, 2021.
153 hedge funds and large institutions have $1.42B invested in Constellation Pharmaceuticals, Inc. in 2021 Q2 according to their latest regulatory filings, with 71 funds opening new positions, 34 increasing their positions, 32 reducing their positions, and 49 closing their positions.
45% more first-time investments, than exits
New positions opened: 71 | Existing positions closed: 49
29% more funds holding in top 10
Funds holding in top 10: 7 → 9 (+2)
17% more funds holding
Funds holding: 131 → 153 (+22)
17% more capital invested
Capital invested by funds: $1.22B → $1.42B (+$204M)
6% more repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 32
57% less call options, than puts
Call options by funds: $16.2M | Put options by funds: $37.7M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$46.6M |
| 2 |
VI
Versor Investments
New York
|
+$40.5M |
| 3 |
AAM
Alpine Associates Management
Palm Beach,
Florida
|
+$25.7M |
| 4 |
Man Group
London,
United Kingdom
|
+$24.2M |
| 5 |
Millennium Management
New York
|
+$21.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VA
VR Adviser
New York
|
-$94M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$88.4M |
| 3 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$52.4M |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$45.8M |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
-$40.4M |
CNST Hedge Fund Activity: Q2 2021 in Review
153 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Constellation Pharmaceuticals, Inc. (CNST) for Q2 2021, worth a combined $1.42B — up 17% from $1.22B a quarter earlier.
Buyers outnumbered sellers: 71 funds opened new CNST positions and 49 closed out — a net gain of 22 holders — while 34 added to existing stakes and 32 trimmed.
The largest buyer was Magnetar Financial, opening a new position worth an estimated $46.6M. The largest seller was VR Adviser, exiting entirely with an estimated $94M sold.
- 153 institutional investors held Constellation Pharmaceuticals, Inc. (CNST) as of Q2 2021, up from 131 in Q1 2021.
- Funds reported $1.42B of Constellation Pharmaceuticals, Inc. stock for Q2 2021, up 17% quarter-over-quarter.
- 71 funds opened new Constellation Pharmaceuticals, Inc. positions in Q2 2021 and 49 closed out, a net change of +22 holders.
- The largest Constellation Pharmaceuticals, Inc. buyer in Q2 2021 was Magnetar Financial, an estimated $46.6M added.
- The largest Constellation Pharmaceuticals, Inc. seller in Q2 2021 was VR Adviser, an estimated $94M sold.
Based on aggregated 13F filings for Q2 2021.